"Nobody noticed that it was available and we werent particularly good at marketing."

— Samuel Bogoch, MD, PhD, founder of Oncolab (Boston), discussing his companys Amas test for detecting cancer in its early stages, which has been FDA-approved since 1977 without making much of an impact commercially, "Oncolabs blood test for early cancer detection re-launched," pp. 1, 6.